Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making

被引：262
|
作者：
Lip, Gregory Y. H. [1 ,2 ,3 ]
Freedman, Ben [4 ,5 ,6 ]
De Caterina, Raffaele [7 ,8 ]
Potpara, Tatjana S. [3 ,9 ]
机构：
[1] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England
[2] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
[3] Univ Belgrade, Sch Med, Belgrade, Serbia
[4] Univ Sydney, Heart Res Inst, Sydney Med Sch, Charles Perkins Ctr, Sydney, NSW, Australia
[5] Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW, Australia
[6] Univ Sydney, Concord Hosp, Anzac Res Inst, Sydney, NSW, Australia
[7] Univ G dAnnunzio, Chieti, Italy
[8] Ctr Excellence Aging CeSI Met, Chieti, Italy
[9] Clin Ctr Serbia, Cardiol Clin, Belgrade, Serbia
来源：
THROMBOSIS AND HAEMOSTASIS | 2017年 / 117卷 / 07期
关键词：
Atrial fibrillation; stroke prevention; non-vitamin K antagonist oral anticoagulants; warfarin; VITAMIN-K ANTAGONIST; MAJOR BLEEDING RISK; DAILY-CARE PATIENTS; VS. USUAL CARE; ISCHEMIC-STROKE; CHA(2)DS(2)-VASC SCORE; ANTITHROMBOTIC THERAPY; ELDERLY-PATIENTS; ORAL ANTICOAGULANTS; COST-EFFECTIVENESS;
D O I：
10.1160/TH16-11-0876
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Concepts and our approaches to stroke prevention in atrial fibrillation (AF) have changed markedly over the last decade. There has been an evolution over the approach to stroke and bleeding risk assessment, as well as new treatment options. An increasing awareness of AF has led to calls to improve the detection of and population screening for AF Stroke and bleeding risk assessment continues to evolve, and the ongoing debate on balance between simplicity and practicality, against precision medicine will continue. In this review article, we provide an overview of past, present and the (likely) future concepts and approaches to stroke prevention in AF We propose three simple steps (the Birmingham '3-step') that offers a practical management pathway to help streamline and simplify decision-making for stroke prevention in patients with AF.
引用
收藏
页码：1230 / 1239
页数：10
相关论文
共 50 条
  • [1] Partnering with patients in shared decision-making for stroke prevention in atrial fibrillation
    Ferguson, Caleb
    Hendriks, Jeroen
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2017, 16 (03) : 178 - 180
  • [2] Past, Present, and Future of Shared Decision-Making
    Matlock, Daniel D.
    Jackson II, Larry R.
    Sandhu, Amneet
    Scherer, Laura D.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2024, 17 (07): : e010584
  • [3] Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
    AlTurki, Ahmed
    Marafi, Mariam
    Russo, Vincenzo
    Proietti, Riccardo
    Essebag, Vidal
    MEDICINA-LITHUANIA, 2019, 55 (10):
  • [4] Decision-making in international marketing: past, present and future
    Oliveira, Joao S.
    Hultman, Magnus
    Boso, Nathaniel
    Hodgkinson, Ian
    Hughes, Paul
    Nemkova, Ekaterina
    Souchon, Anne
    INTERNATIONAL MARKETING REVIEW, 2023, 40 (03) : 413 - 428
  • [5] Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views
    Wang, Yishen
    Bajorek, Beata
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (04) : 985 - 995
  • [6] Design and development of a digital shared decision-making tool for stroke prevention in atrial fibrillation
    Nunes, Julio C.
    Baykaner, Tina
    Pundi, Krishna
    DeSutter, Katie
    Hills, Mellanie True
    Mahaffey, Kenneth W.
    Sears, Samuel F.
    Morin, Daniel P.
    Lin, Bryant
    Wang, Paul J.
    Stafford, Randall S.
    JAMIA OPEN, 2023, 6 (01)
  • [7] Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals’ views
    Yishen Wang
    Beata Bajorek
    International Journal of Clinical Pharmacy, 2016, 38 : 985 - 995
  • [8] Can Shared Decision Making Improve Stroke Prevention in Atrial Fibrillation? Implications of the Updated Guidelines
    Brand-McCarthy, Sarah R.
    Delaney, Rebecca K.
    Noseworthy, Peter A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (03):
  • [9] Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway
    Wang, Paul J.
    Lu, Ying
    Mahaffey, Kenneth W.
    Lin, Amy
    Morin, Daniel P.
    Sears, Samuel F.
    Chung, Mina K.
    Russo, Andrea M.
    Lin, Bryant
    Piccini, Jonathan
    Hills, Mellanie True
    Berube, Caroline
    Pundi, Krishna
    Baykaner, Tina
    Garay, Gotzone
    Lhamo, Karma
    Rice, Eli
    Pourshams, Idean A.
    Shah, Rushil
    Newswanger, Paul
    DeSutter, Katie
    Nunes, Julio Cesar
    Albert, Michelle A.
    Schulman, Kevin A.
    Heidenreich, Paul A.
    Bunch, T. Jared
    Sanders, Lee M.
    Turakhia, Mintu
    Verghese, Abraham
    Stafford, Randall S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (03):
  • [10] Assessment of Shared Decision-making for Stroke Prevention in Patients With Atrial Fibrillation A Randomized Clinical Trial
    Kunneman, Marleen
    Branda, Megan E.
    Hargraves, Ian G.
    Sivly, Angela L.
    Lee, Alexander T.
    Gorr, Haeshik
    Burnett, Bruce
    Suzuki, Takeki
    Jackson, Elizabeth A.
    Hess, Erik
    Linzer, Mark
    Brand-McCarthy, Sarah R.
    Brito, Juan P.
    Noseworthy, Peter A.
    Montori, Victor M.
    JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1215 - 1224
12345